309 related articles for article (PubMed ID: 11493692)
1. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor.
Zheng L; Annab LA; Afshari CA; Lee WH; Boyer TG
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9587-92. PubMed ID: 11493692
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
3. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
[TBL] [Abstract][Full Text] [Related]
5. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 inhibition of estrogen receptor signaling in transfected cells.
Fan S; Wang J; Yuan R; Ma Y; Meng Q; Erdos MR; Pestell RG; Yuan F; Auborn KJ; Goldberg ID; Rosen EM
Science; 1999 May; 284(5418):1354-6. PubMed ID: 10334989
[TBL] [Abstract][Full Text] [Related]
7. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
8. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
10. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
[TBL] [Abstract][Full Text] [Related]
11. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.
Herynk MH; Hopp T; Cui Y; Niu A; Corona-Rodriguez A; Fuqua SA
Breast Cancer Res Treat; 2010 Jul; 122(2):381-93. PubMed ID: 19842032
[TBL] [Abstract][Full Text] [Related]
12. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms.
Platet N; Cunat S; Chalbos D; Rochefort H; Garcia M
Mol Endocrinol; 2000 Jul; 14(7):999-1009. PubMed ID: 10894150
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of BRCA1 in transcriptional regulation and DNA repair.
Chen Y; Lee WH; Chew HK
J Cell Physiol; 1999 Dec; 181(3):385-92. PubMed ID: 10528224
[TBL] [Abstract][Full Text] [Related]
14. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
Stoica A; Pentecost E; Martin MB
Endocrinology; 2000 Oct; 141(10):3595-602. PubMed ID: 11014213
[TBL] [Abstract][Full Text] [Related]
15. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
17. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
18. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
19. Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
Johnsen SA; Güngör C; Prenzel T; Riethdorf S; Riethdorf L; Taniguchi-Ishigaki N; Rau T; Tursun B; Furlow JD; Sauter G; Scheffner M; Pantel K; Gannon F; Bach I
Cancer Res; 2009 Jan; 69(1):128-36. PubMed ID: 19117995
[TBL] [Abstract][Full Text] [Related]
20. Increases in estrogen receptor-alpha concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen.
Fowler AM; Solodin N; Preisler-Mashek MT; Zhang P; Lee AV; Alarid ET
FASEB J; 2004 Jan; 18(1):81-93. PubMed ID: 14718389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
